Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Studies of thymopoietin pentapeptide (TP5) on experimental tumors. I. TP5 relieves immunosuppression in tumor-bearing mice.

× No keyword cloud information.

13 in total

1. Modulation of NK activity by thymic hormones: in vitro effects of thymostimulin.

Authors: A M Liberati; S Cinieri; M Fizzotti; M Schippa; S Ascani; V De Angelis; M Senatore; L Palmisano
Journal: Med Oncol Tumor Pharmacother Date: 1989

2. Thymic factor-induced reduction of pulmonary metastases in mice with FSA-1 fibrosarcoma.

Authors: V J Tomazic; C R Sacasa; A Loftus; C S Suter; G E Elias
Journal: Clin Exp Metastasis Date: 1988 Jan-Feb Impact factor: 5.150

3. Thymopentin: stability considerations and potency by various routes of administration.

Authors: T K Audhya; G Goldstein
Journal: Surv Immunol Res Date: 1985

4. Prevention of recurrences in frequently relapsing herpes labialis with thymopentin. A randomized double-blind placebo-controlled multicenter study.

Authors: K Bolla; D Djawari; E M Kokoschka; J Petres; S Lidén; R Gonseth; P Amblard; M G Bernengo; J J Bonerandi; A Claudy
Journal: Surv Immunol Res Date: 1985

Review 5. Biological response modifiers and differentiation inducers. Current status in cancer research.

Authors: P Reizenstein; G Mathé
Journal: Drugs Date: 1983-09 Impact factor: 9.546

6. In vitro influence of thymopentin on proliferative responses and phytohemagglutinin-induced interleukin 2 production in normal human lymphocyte cultures.

Authors: J Duchateau; G Servais; R Cooman; H Collet; K Bolla
Journal: Surv Immunol Res Date: 1985

7. Thymopentin treatment in patients with chemotherapy-resistant lepromatous leprosy.

Authors: A Castells; J Terencio; A Ramirez; E Sundal; K Bolla
Journal: Surv Immunol Res Date: 1985

8. Contrasting biological activities of thymopoietin and splenin, two closely related polypeptide products of thymus and spleen.

Authors: T Audhya; M P Scheid; G Goldstein
Journal: Proc Natl Acad Sci U S A Date: 1984-05 Impact factor: 11.205

9. The immune system response during development and progression of carcinogen-induced rat mammary tumors: prevention of tumor growth and restoration of immune system responsiveness by thymopentin.

Authors: F Gallo; M C Morale; D Sambataro; Z Farinella; U Scapagnini; B Marchetti
Journal: Breast Cancer Res Treat Date: 1993-09 Impact factor: 4.872

10. Immune regulation effect of lienal polypeptides extract in Lewis lung carcinoma-bearing mice treated with cyclophosphamide.

Authors: Yan-Ping Wu; Jie Deng; Shu-Hua Ouyang; Zhong-Fu Mao; Guo-En Wang; Hiroshi Kurihara; Rong-Rong He; Yi-Fang Li
Journal: Exp Biol Med (Maywood) Date: 2017-10-27